TET2 and non-Hodgkin lymphoma: The associations of overall NHL described above (Table 2) with the risk variants for lung cancer (rs3131379 in MSH5) and prostate cancer (rs7679673 in TET2) appeared to be due to their associations with the risk of DLBCL subtype [OR per allele T in rs3131379 = 1.41 (1.10–1.80), p = 0.0061; OR per allele C in rs7679673 = 0.83 (0.71–0.98), p = 0.030].